Cargando…

Predictors of dopamine dysregulation syndrome in patients with early Parkinson’s disease

BACKGROUND: Dopamine dysregulation syndrome (DDS) is a complication of Parkinson’s disease (PD) that seriously affects the quality of life of PD patients. Currently, the risk factors for DDS are poorly known, and it is critical to identify them in the early stages of PD. OBJECTIVE: To explore the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Keke, Li, Xiaohuan, Ma, Jianjun, Yang, Hongqi, Shi, Xiaoxue, Fan, Yongyan, Yang, Dawei, Guo, Dashuai, Liu, Chuanze, Dong, Linrui, Chang, Qingqing, GU, Qi, Chen, Siyuan, Li, Dongsheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641065/ https://www.ncbi.nlm.nih.gov/pubmed/37452260 http://dx.doi.org/10.1007/s10072-023-06956-w

Ejemplares similares

miR-494-3p Promotes Erastin-Induced Ferroptosis by Targeting REST to Activate the Interplay between SP1 and ACSL4 in Parkinson's Disease
por: Ma, Jianjun, et al.
Publicado: (2022)

MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3
por: Li, Dongsheng, et al.
Publicado: (2017)

MicroRNA-181a–2–3p shuttled by mesenchymal stem cell-secreted extracellular vesicles inhibits oxidative stress in Parkinson’s disease by inhibiting EGR1 and NOX4
por: Ma, Jianjun, et al.
Publicado: (2022)

Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson’s disease patients
por: Shi, Xiaoxue, et al.
Publicado: (2022)

Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease
por: Li, Mingjian, et al.
Publicado: (2022)

Acquired dysregulation of dopamine homeostasis reproduces features of Parkinson’s disease
por: Bucher, Meghan L., et al.
Publicado: (2020)

Dopamine Dysregulation Syndrome and Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
por: De la Casa-Fages, Beatriz, et al.
Publicado: (2011)

Case report: Dopamine Dysregulation Syndrome, mania, and compulsive buying in a patient with Parkinson's disease
por: Silva, Carlos, et al.
Publicado: (2023)

Calcium dysregulation combined with mitochondrial failure and electrophysiological maturity converge in Parkinson’s iPSC-dopamine neurons
por: Beccano-Kelly, Dayne A., et al.
Publicado: (2023)

Preparation of Pd/Bacterial Cellulose Hybrid Nanofibers for Dopamine Detection
por: Li, Dawei, et al.
Publicado: (2016)

Dopamine System Dysregulation in Major Depressive Disorders
por: Belujon, Pauline, et al.
Publicado: (2017)

Dysregulation of Midbrain Dopamine System and the Pathophysiology of Schizophrenia
por: Sonnenschein, Susan F., et al.
Publicado: (2020)

Dopamine dysregulation syndrome after prescription of dopamine agonists: a case report
por: Costa, M.L., et al.
Publicado: (2022)

Parkinson’s Disease is Associated with Dysregulations of a Dopamine-Modulated Gene Network Relevant to Sleep and Affective Neurobehaviors in the Striatum
por: Jiang, Peng, et al.
Publicado: (2019)

Dysregulation of oxytocin and dopamine in the corticostriatal circuitry in bipolar II disorder
por: Wei, Shyh-Yuh, et al.
Publicado: (2020)

The biomarkers of immune dysregulation and inflammation response in Parkinson disease
por: Chen, Li, et al.
Publicado: (2016)

Clostridioides difficile Infection Dysregulates Brain Dopamine Metabolism
por: Vinithakumari, Akhil A., et al.
Publicado: (2022)

Dysregulation of autophagy and mitochondrial function in Parkinson’s disease
por: Wang, Bao, et al.
Publicado: (2016)

Successful treatment of dopamine dysregulation syndrome with dopamine D(2) partial agonist antipsychotic drug
por: Mizushima, Jin, et al.
Publicado: (2012)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Intracerebroventricular dopamine for Parkinson's disease
por: Devos, David, et al.
Publicado: (2017)

Circadian dysregulation in Parkinson's disease
por: Videnovic, Aleksandar, et al.
Publicado: (2016)

Increased Plasma Heme Oxygenase-1 Levels in Patients With Early-Stage Parkinson’s Disease
por: Sun, Wenhua, et al.
Publicado: (2021)

The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission
por: Sambo, Danielle O., et al.
Publicado: (2017)

HIV-1 proteins dysregulate motivational processes and dopamine circuitry
por: Bertrand, Sarah J., et al.
Publicado: (2018)

Dysregulation of dopamine neurotransmission in the nucleus accumbens in immobilization-induced hypersensitivity
por: Kishikawa, Yuki, et al.
Publicado: (2022)

Conditional deletion of neurexins dysregulates neurotransmission from dopamine neurons
por: Ducrot, Charles, et al.
Publicado: (2023)

The treatment of Parkinson's disease with dopamine agonists
por: Konta, Brigitte, et al.
Publicado: (2008)

Role of dopamine in the pathophysiology of Parkinson’s disease
por: Zhou, Zhi Dong, et al.
Publicado: (2023)

Impaired dopamine release in Parkinson’s disease
por: Cramb, Kaitlyn M L, et al.
Publicado: (2023)

Dysregulation of Corticostriatal Connectivity in Huntington’s Disease: A Role for Dopamine Modulation
por: Rangel-Barajas, Claudia, et al.
Publicado: (2016)

Neuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems
por: Wawrzczak-Bargieła, Agnieszka, et al.
Publicado: (2020)

The role of tyrosine hydroxylase–dopamine pathway in Parkinson’s disease pathogenesis
por: Zhou, Zhi Dong, et al.
Publicado: (2022)

Elevated Plasma Melatonin Levels Are Correlated With the Non-motor Symptoms in Parkinson’s Disease: A Cross-Sectional Study
por: Li, Linyi, et al.
Publicado: (2020)

Correlation of Decreased Serum Pituitary Adenylate Cyclase-Activating Polypeptide and Vasoactive Intestinal Peptide Levels With Non-motor Symptoms in Patients With Parkinson’s Disease
por: Hu, Shiyu, et al.
Publicado: (2021)

Candidate Genes Encoding Dopamine Receptors as Predictors of the Risk of Antipsychotic-Induced Parkinsonism and Tardive Dyskinesia in Schizophrenic Patients
por: Vaiman, Elena E., et al.
Publicado: (2021)

Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease
por: Park, Ariane, et al.
Publicado: (2011)

Dopamine Agonist Therapy in Advanced Parkinson’s Disease
por: Reichmann, Heinz
Publicado: (2009)

The effects of dopamine on digit span in Parkinson’s disease
por: Warden, Clara, et al.
Publicado: (2016)

Dopamine and Levodopa Prodrugs for the Treatment of Parkinson’s Disease
por: Haddad, Fatma, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_iqfaen4oif3nvfrlmo1mthoe1p